German China

Biospecimens Ethically Sourced Samples

Source: Press release Amsbio 1 min Reading Time

Related Vendor

Amsbio now offers an unmatched range of customizable human blood biospecimens from both healthy and disease-state donors to support biomedical research.

PMBC vials for immunology and oncology research.(Source:  Amsbio)
PMBC vials for immunology and oncology research.
(Source: Amsbio)

Amsbio has expanded its biofluid collection and processing capabilities, to now offer an unmatched range of customizable human blood biospecimens from both healthy and disease-state donors to support biomedical research.

Leveraging an extensive network of diverse donors, the company provides high-quality, ethically sourced samples tailored to specific donor demographics, sample volumes, and processing methods.

Using a fully licensed sample collection and processing facility, the firm can ensure the highest standards of traceability and compliance. The expanded portfolio includes leukopaks, plasma, serum, whole blood, peripheral blood mononuclear cells (PBMCs), and isolated immune cells, all processed to meet precise research specifications.

Unlike national blood banks, Amsbio provides greater flexibility in donor selection and consent, enabling researchers to access fully authorized samples for commercial research to support applications including drug development, cell therapy, and regenerative medicine, shares the company.

Designed to advance research in multiple therapeutic areas, including oncology, autoimmune diseases, and neurodegenerative conditions, Amsbio biospecimens allow researchers to access donor cohorts that precisely match the unique requirements of their studies.

In addition, the company can now offer rapid processing and overnight delivery of fresh, customized biofluids to researchers throughout Europe. This service is planned to be expanded into North America in the future, further extending access to its bespoke sample collection services, concludes the firm.

(ID:50941027)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent